FDA Issues Discussion Paper Regarding Regulation of Generative AI-Enabled Medical Devices
FDA Issues Discussion Paper Regarding Regulation of Generative AI-Enabled Medical Devices
The FDA’s recent discussion paper seeking feedback regarding the regulation of generative AI-enabled medical devices suggests that the FDA has focused on evaluating, monitoring, and regulating such devices amid increasing commercialization.... By: Knobbe Martens
Related News
California Lawmakers Pass Bill to Curb Website Tracking Lawsuits: What Businesses With Pending Claims Should Do Now
Unknownabout 1 hour ago
[Video] Hot Topics in International Trade Braumiller Law Group's VP Bob Brewer is joined by DC Counsel Jim Holbein to discuss The Genius Act, Stablecoin, and the upcoming regulations.mov
Unknownabout 3 hours ago
[Video] The New Rules of Smartphone Collection
Unknownabout 3 hours ago